Clinical Trial Update: The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy, safety, and pharmacokinetics of vicagrel as an antiplatelet therapy in coronary artery disease patients undergoing percuta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Percutaneous Coronary Intervention

Drugs mentioned

• Vicagrel (vicagrel)

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 2 | Status: COMPLETED